Barrett's esophagus: is dysplasia a reliable marker in surveillance after endoscopic treatment?

Curr Gastroenterol Rep. 2001 Oct;3(5):371-4. doi: 10.1007/s11894-001-0075-7.

Author

M A Ortner¹

Affiliation

¹ Department of Gastroenterology/Hepatology, Humboldt University, Medical Faculty Charité, CCM, Schumannstrasse 20-21, D 10117 Berlin, Germany. Marianne.Ortner@charite.de

PMID: 11560793
DOI: 10.1007/s11894-001-0075-7

No abstract available

MeSH terms

Adenocarcinoma / diagnosis*
Adenocarcinoma / genetics
Adenocarcinoma / therapy*
Barrett Esophagus / diagnosis*
Barrett Esophagus / genetics
Barrett Esophagus / therapy*
Cell Transformation, Neoplastic
Combined Modality Therapy
Enzyme Inhibitors / therapeutic use
Esophageal Neoplasms / diagnosis*
Esophageal Neoplasms / genetics
Esophageal Neoplasms / therapy*
Esophagectomy
Esophagoscopy
Esophagus / pathology*
Humans
Neoplasm Recurrence, Local
Photochemotherapy
Population Surveillance
Precancerous Conditions / diagnosis*
Precancerous Conditions / genetics
Precancerous Conditions / therapy*
Predictive Value of Tests
Spectrum Analysis / methods

Substances

Enzyme Inhibitors